These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1724612

  • 21. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
    Miyachi H, Jiao L, Sowers LC, Scanlon KJ.
    In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR, James RI, May C, Diers MD, Swanson D, Gunther R, McIvor RS.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [Abstract] [Full Text] [Related]

  • 23. Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells.
    Yu M, Melera PW.
    Cancer Res; 1993 Dec 15; 53(24):6031-5. PubMed ID: 8261418
    [Abstract] [Full Text] [Related]

  • 24. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
    McIvor RS.
    Bone Marrow Transplant; 1996 Dec 15; 18 Suppl 3():S50-4. PubMed ID: 8971409
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI, May C, Vagt MD, Studebaker R, McIvor RS.
    Exp Hematol; 1997 Nov 15; 25(12):1286-95. PubMed ID: 9357973
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A qualitative and quantitative assay of dihydrofolate reductase in carrot cells resistant to methotrexate.
    Nano R, Cella R, Rezzani R, Rodella L, Gerzeli G.
    Basic Appl Histochem; 1989 Nov 15; 33(2):81-92. PubMed ID: 2757603
    [Abstract] [Full Text] [Related]

  • 29. [Methotrexate and its drug resistance].
    Nagura E.
    Gan To Kagaku Ryoho; 1988 Oct 15; 15(10):2882-7. PubMed ID: 3178237
    [Abstract] [Full Text] [Related]

  • 30. Flow cytometric analysis of mammalian glial cultures treated with methotrexate.
    Serrano EE, Schimke RT.
    Glia; 1990 Oct 15; 3(6):539-49. PubMed ID: 2148556
    [Abstract] [Full Text] [Related]

  • 31. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
    Cowan KH, Goldsmith ME, Ricciardone MD, Levine R, Rubalcaba E, Jolivet J.
    Mol Pharmacol; 1986 Jul 15; 30(1):69-76. PubMed ID: 3724746
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H, Niethammer D, Jackson RC.
    Cancer Res; 1983 Nov 15; 43(11):5286-92. PubMed ID: 6225514
    [Abstract] [Full Text] [Related]

  • 34. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW, Nikaido O, Kobayashi N, Chang CC, Trosko JE, Mori T.
    Carcinogenesis; 1996 Mar 15; 17(3):389-94. PubMed ID: 8631121
    [Abstract] [Full Text] [Related]

  • 35. [MTX resistant mechanisms in human choriocarcinoma cells].
    Sakai K, Fujino T, Hoshi S, Shinkai N, Hashimoto M, Yasuda T, Kato H, Yamada H, Wake N, Ichinoe K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May 15; 39(5):807-14. PubMed ID: 3474305
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A single point mutation in Drosophila dihydrofolate reductase confers methotrexate resistance to a transgenic CHO cell line.
    Neumann K, Al-Batayneh KM, Kuiper MJ, Parsons-Sheldrake J, Tyshenko MG, Flintoff WF, Cole SP, Walker VK.
    Genome; 2003 Aug 15; 46(4):707-15. PubMed ID: 12897877
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
    Srimatkandada S, Schweitzer BI, Moroson BA, Dube S, Bertino JR.
    J Biol Chem; 1989 Feb 25; 264(6):3524-8. PubMed ID: 2914962
    [Abstract] [Full Text] [Related]

  • 40. Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance.
    Morris JA, McIvor RS.
    Biochem Pharmacol; 1994 Mar 29; 47(7):1207-20. PubMed ID: 8161350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.